US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
ブラジル
BOV
Barclays plc (B1CS34) 銘柄情報

Barclays plc (B1CS34)

138.19

0.00

(0.00%)

終了 6月22日 5:55AM

Barclays plc (B1CS34) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

138.19

( - )

買値

0.00

売値

1,193.59

出来高

-

0.00 日の範囲 0.00

94.80 52 週間の範囲 145.88

時価総額

前日終値

138.19

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

R$ 60,478,898

発行済株式数

13,512,771,040

配当利回り

(1.98%)

PER

10.95

1 株当たり利益 (EPS)

0.43

歳入

27.09B

純利益

7.25B

Barclays PLC provides various financial services in the United Kingdom, Europe, the Americas, Africa, the Middle East, and Asia. The company operates through Barclays UK; Barclays UK Corporate Bank; Barclays Private Bank and Wealth Management; Barclays Investment Bank; and Barclays US Consumer Bank ... Barclays PLC provides various financial services in the United Kingdom, Europe, the Americas, Africa, the Middle East, and Asia. The company operates through Barclays UK; Barclays UK Corporate Bank; Barclays Private Bank and Wealth Management; Barclays Investment Bank; and Barclays US Consumer Bank segments. It offers financial services, such as current accounts, savings accounts, mortgages and unsecured lending, such as credit cards and loans retail banking, wholesale banking, investment banking, wealth management, and investment management services, as well as lending products. In addition, the company engages in securities dealing activities and issuing of credit cards. The company was formerly known as Barclays Bank public limited company and changed its name to Barclays PLC in January 1985. Barclays PLC was founded in 1690 and is headquartered in London, the United Kingdom. 詳細を表示

セクター

-

業界

-

ウェブサイト

home.barclays

本社

London, United Kingdom

設立

1690

Barclays plc is listed in the sector of the ボベスパ (ブラジル) with ticker B1CS34. The last closing price for Barclays was R$138.19. Over the last year, Barclays shares have traded in a share price range of R$ 94.80 to R$ 145.88.

Barclays currently has 13,512,771,040 shares in issue. The market capitalisation of Barclays is R$1.87 trillion. Barclays has a price to earnings ratio (PE ratio) of 10.95.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	7.19	5.48854961832	131	138.19	130.08	72	134.37139373	DR
4	17.07	14.0934610304	121.12	138.19	121.12	207	123.33903579	DR
12	25.66	22.8028081401	112.53	138.19	106.75	108	120.22073684	DR
26	-0.55	-0.396424967565	138.74	145.88	105.6	103	127.85333732	DR
52	43.29	45.6164383562	94.9	145.88	94.8	112	118.54716101	DR
156	99.75	259.495317378	38.44	145.88	31.26	205	68.71272462	DR
260	89.3	182.65493966	48.89	145.88	31.26	505	52.61024525	DR

B1CS34 - Frequently Asked Questions (FAQ)

What is the current Barclays plc share price?

The current share price of Barclays plc is R$ 138.19

How many Barclays plc shares are in issue?

Barclays plc has 13,512,771,040 shares in issue

What is the market cap of Barclays plc?

The market capitalisation of Barclays plc is BRL 1.87T

What is the 1 year trading range for Barclays plc share price?

Barclays plc has traded in the range of R$ 94.80 to R$ 145.88 during the past year

What is the PE ratio of Barclays plc?

The price to earnings ratio of Barclays plc is 10.95

What is the cash to sales ratio of Barclays plc?

The cash to sales ratio of Barclays plc is 2.36

What is the registered address of Barclays plc?

The registered address for Barclays plc is 1 Churchill Place, London, Greater London, E14 5HP

What is the Barclays plc website address?

The website address for Barclays plc is home.barclays

waterchaser

waterchaser 1分前

Looks like a RS incoming.

SmallCapStockAlert

SmallCapStockAlert 3分前

SHORT PATHWAY TO REVENUES
>Cardiovascular Disease
>Cancer Treatments
>Blood Purification
>Infectious Disease
>Inflammation
>BioDefense
>Ebola
https://richardacavalli.wixsite.com/greenplanetmicrocaps/market-overlooked-sigy

ipiros

https://x.com/rigatoni33/status/2068835362013618196?s=46&t=1mtQtgXmx35-BlWutjUYiQ
Thanks Rigatoni!

fuagf

Glad he hung on though i was on Burns who almost got there. And yes, well done to all who were on the winner.

Werbe

We shouldn't be guessing anymore because there is nothing hidden on our plate. Jessika has businesses to put in here and that's who owns this now. I dont see them trading it to her in this way if she is a shell flipper. There would've been money in the deal. Jessika takes over and at the end of

MrPennyBags

MrPennyBags 15分前

I don't like to say it couldn't get much lower but I don't want to be proven wrong on that one.

jara-mill

jara-mill 15分前

$HHSE: The harder we work... the luckier we get...

Sunday May 31st, 2026

(Click on this link to view photos)

https://hannoverhousemovies.blogspot.com/2026/05/the-harder-we-work-luckier-we-get.html HHSE Blog - Latest News

Dear HHSE Friend

jara-mill

jara-mill 15分前

No one except Shorts, Eric haters and the Jealous care about their own posts! All hoping Eric doesn't come through with inevitable success!!! HUUUUGE ANNOUNCEMENTS of HUUUUGE ACCOMPLISHMENTS IMMINENT!!! WHALES LURKING, HANGRY and poised to MUNCH!!! ONWARD!!!

MasterBlastr

MasterBlastr 16分前

Tough battle for Clark, will see if he makes the front page of the Denver Post tomorrow. Gret work all the Clark pickers, seems like an obvious choice after the fact.

Golden Cross

Golden Cross 16分前

Lets burn the shorts....................

Zilla

Now 4 years after BLCO IPO and BHC still has the 88% of BLCO.
BLCO is currently 14.87 and BHC 4.77. What a fine MESS this has been. Ichan sold to Paulson his 9-10% stake for 9 bucks. Uncle Carl should buy that all back in the open market under 6 bucks. Especially being he sold the BHC positio

3Angels120702

3Angels120702 19分前

Yawn and double yawn. You still haven't posted the world wide contract with the Hong Kong firm and Breakthrough Crapistry.

DewDiligence

DewDiligence 20分前

Biotech Buyout Info—more_detail_than_the_table_ maintained_here; see direct link at bottom on this iHub post.
https://twitter.com/plainyogurt21/status/2068703078967341088
https://github.com/plainyogurt21/biotech-buyouts

manibiotech

manibiotech 23分前

I believe Meirluc was taking about Flasworks and not artisan method . That’s the difference .

Mr. C

Spot or not, they likely won’t dilute the stock by $5 billion that far away from revenue.

They could do that or even 100% debt, but it’s a trade-off. I think preserving the long-term value of the stock probably offers a much greater benefit.

Diluting that much, that ear

againstallodds

againstallodds 26分前

Hyping Harpreet: 0 employees for this POS

YOU KEEP GOING IN THE SHARE SELLING BUSINESS

EVEN IF YOUS BADLY FAILED WITH GNCP & CDSG !!!

flipper44

flipper44 28分前

NVCR’s 17.5 and 17.7 median overall survival in the trident trial is not impressive for the following reasons, imo.

1. They used the old less aggressive definition of GBM.

2. They started randomization after surgery recovery but before chemoradiation started. This al

trunkmonk

trunkmonk 28分前

there are no signals but down, all friday, and thus far today.

jesster64

jesster64 28分前

If manufacturing is the holdup. why is everyone posting on this board? Just wait for manufacturing to catch up.

Kallike

Kallike 29分前

As a matter of fact VMHG hit $3.69 on 03.16.2021 at a quarter of what the share structure it has right now. So yes, with a little win this could hit a DOLLAR all day long.

Lord Andreti

Lord Andreti 29分前

My man, with all due respect, you are extremely underestimating the power of $1 million in original shares and a stacked bid that refuses to give up and needs more. Like to the point of ignorance.

When that changes and we see a stacked ask and people desperately trying to get rid of

Dacloud1

Dacloud1 31分前

Wow, closer to $18.00 then minus $18.00 yah

Kallike

Kallike 35分前

Call a card reader better!

cybldron

cybldron 36分前

ditto brother....

beartrap12

beartrap12 36分前

Keep in mind, Mani, that Sawston is on leased land. I don't see any differece between securing an MAA at Sawston and securing it with another C-room facility through a lease.

Norfolk Southern

NAOS Ex 50 Opportunities

Calamos Dynamic Converti...

Ascendis Pharma AS

Eagle Point Credit

Ashler Et Manson

Brandes Us Equity Fund S...

iShares S&P 500 Scored a...

Asian Terminals (EM)

PARK ADSITS SOFIA PARK

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。